carbamates has been researched along with Bile Duct Obstruction in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " A 49-year-old female developed a severe recurrent HCV genotype 1b infection 4 months after transplantation with severe cholestasis on biopsy, an HCV RNA level of 10,000,000 IU/mL, an alkaline phosphatase level of 1525 IU/mL, and a total bilirubin level of 8." | 7.78 | Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. ( Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA, 2012) |
| " A 49-year-old female developed a severe recurrent HCV genotype 1b infection 4 months after transplantation with severe cholestasis on biopsy, an HCV RNA level of 10,000,000 IU/mL, an alkaline phosphatase level of 1525 IU/mL, and a total bilirubin level of 8." | 3.78 | Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. ( Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA, 2012) |
| "Cholestasis is associated with increased activity of the endogenous opioid system that results in analgesia." | 1.35 | Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis. ( Hasanein, P; Komaki, A; Mirazi, N; Shahidi, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontana, RJ | 2 |
| Hughes, EA | 2 |
| Bifano, M | 2 |
| Appelman, H | 2 |
| Dimitrova, D | 2 |
| Hindes, R | 2 |
| Symonds, WT | 1 |
| Leroy, V | 1 |
| Dumortier, J | 1 |
| Coilly, A | 1 |
| Sebagh, M | 1 |
| Fougerou-Leurent, C | 1 |
| Radenne, S | 1 |
| Botta, D | 1 |
| Durand, F | 1 |
| Silvain, C | 1 |
| Lebray, P | 1 |
| Houssel-Debry, P | 1 |
| Kamar, N | 1 |
| D'Alteroche, L | 1 |
| Petrov-Sanchez, V | 1 |
| Diallo, A | 1 |
| Pageaux, GP | 1 |
| Duclos-Vallee, JC | 1 |
| Hasanein, P | 1 |
| Shahidi, S | 1 |
| Komaki, A | 1 |
| Mirazi, N | 1 |
| López-García, F | 1 |
| Borrás, J | 1 |
| Verdú, C | 1 |
| Salazar, VR | 1 |
| Ruiz, JA | 1 |
| Sales, J | 1 |
| Lucena, MI | 1 |
| Andrade, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cohort of Liver Transplanted Patients With Hepatitis C Virus Recurrence and Treated With Direct-acting Antiviral Agents[NCT01944527] | 699 participants (Actual) | Observational | 2013-10-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbamates and Bile Duct Obstruction
| Article | Year |
|---|---|
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.
Topics: Antiviral Agents; Belgium; Carbamates; Cholestasis; Drug Therapy, Combination; Drug-Related Side Eff | 2015 |
4 other studies available for carbamates and Bile Duct Obstruction
| Article | Year |
|---|---|
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.
Topics: Carbamates; Cholestasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Stud | 2013 |
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Cholestasis; Disease Models, Animal; Injections, I | 2008 |
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy | 2012 |
Cholestatic hepatitis associated with repaglinide.
Topics: Aged; Carbamates; Chemical and Drug Induced Liver Injury; Cholestasis; Diabetes Mellitus, Type 2; Hu | 2005 |